CRISPR Clinical Trials To Follow In 2024 And Beyond
Source: Synthego Corporation
CRISPR technology is being increasingly used in clinical trials for a variety of genomic medicines. This article discusses a variety of current and upcoming CRISPR clinical trials, from genetic disorders to infectious diseases and cancer. Some of these trials including CAR-T cell therapies by BEAM Therapeutics, CRISPR Therapeutics, Fate Therapeutics, and Caribou Biosciences.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Synthego Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more